Dudediligence.

Madrigal Pharmaceuticals, Inc

MDGLNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$108.8M

30 notices · 204,983 sh

Oct 2025 to Oct 2026

Reported ·

$73.5M

167 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

146 of 167 reported sales carry the 10b5-1 box. Together they are 0.61% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-28: PAUL FRIEDMAN, Form 1442026-09-11: WILLIAM SIBOLD, Form 1442026-09-09: William John Sibold, Form 1442026-08-17: Shannon Kelley, Form 1442026-07-20: William Sibold, Form 1442026-06-01: DAVID SOERGEL, Form 1442026-05-22: RICHARD LEVY, Form 1442026-05-18: David Soergel, Form 1442026-03-06: MARDI DIER, Form 1442026-03-06: Mardi Dier, Form 1442026-03-06: William Sibold, Form 1442026-03-06: Shannon Kelley, Form 1442026-03-06: Carole Huntsman, Form 1442026-03-06: Rebecca Taub, Form 1442026-03-02: Mardi Dier, Form 1442026-01-26: CAROLE A HUNTSMAN, Form 1442026-01-26: Carole Huntsman, Form 1442026-01-26: William Sibold, Form 1442026-01-26: Rebecca Taub, Form 1442026-01-20: SHANNON KELLEY, Form 1442026-01-20: Shannon Kelley, Form 1442026-01-20: Rebecca Taub, Form 1442026-01-09: REBECCA A TAUB, Form 1442025-12-10: PAUL FRIEDMAN, Form 1442025-12-10: REBECCA A TAUB, Form 1442025-12-04: William John Sibold, Form 1442025-12-02: MARDI C DIER, Form 1442025-11-21: Carole Huntsman, Form 1442025-11-13: RICHARD S LEVY, Form 1442025-11-05: KENNETH M BATE, Form 1442025-11-05: BATE KENNETH, sold2025-11-13: Levy Richard S, sold2025-11-21: Huntsman Carole, sold2025-12-02: Dier Mardi, sold2025-12-04: Sibold William John, sold2025-12-10: Taub Rebecca, sold2025-12-10: FRIEDMAN PAUL A, sold2026-01-09: Taub Rebecca, sold2026-01-09: Taub Rebecca, sold2026-01-09: FRIEDMAN PAUL A, sold2026-01-09: FRIEDMAN PAUL A, sold2026-01-20: Taub Rebecca, sold2026-01-20: Kelley Shannon T, sold2026-01-26: Taub Rebecca, sold2026-01-26: Sibold William John, sold2026-01-26: Huntsman Carole, sold2026-03-02: Dier Mardi, sold2026-03-06: Taub Rebecca, sold2026-03-06: Huntsman Carole, sold2026-03-06: Kelley Shannon T, sold2026-03-06: Sibold William John, sold2026-03-06: Dier Mardi, sold2026-05-18: Soergel David, sold2026-05-22: Levy Richard S, sold2026-06-01: Soergel David, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-28PAUL FRIEDMAN, Director$25.8M
50,000 shplan 2026-08-28Form 4s on file end Jun 23144 ↗
2026-09-11WILLIAM SIBOLD, President and CEO$2,783,420
5,221 shplan 2026-06-05Form 4s on file end Jun 23144 ↗
2026-09-09William John Sibold, President and CEO$3,398,326
6,362 shplan 2026-06-05Form 4s on file end Jun 23144 ↗
2026-08-17Shannon Kelley, General Counsel$337,020
664 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-20William Sibold, President and CEO$1,383,700
2,500 shplan 2026-06-05Form 4s on file end Jun 23144 ↗
2026-06-01DAVID SOERGEL, Chief Medical Officer$518,155
1,042 shplan 2026-03-02144 ↗
Form 4, 2026-06-01: sold 1,042 at $495.74 Form 4 ↗
2026-05-22RICHARD LEVY, Director$2,918,218
5,682 shplan 2026-02-20144 ↗
Form 4, 2026-05-22: sold 5,682 at $515.44 Form 4 ↗
2026-05-18David Soergel, Chief Medical Officer$441,994
844 shplan 2026-03-02144 ↗
Form 4, 2026-05-18: sold 844 at $515.90 Form 4 ↗
2026-03-06MARDI DIER, EVP and CFO$586,958
1,336 shplan 2025-09-02144 ↗
Form 4, 2026-03-06: sold 1,982 at $430.87 Form 4 ↗
2026-03-06Mardi Dier, EVP and CFO$283,814
646 shplan 2025-09-02no Form 4 on file144 ↗
2026-03-06William Sibold, President and CEO$730,622
1,663 shno plan date144 ↗
Form 4, 2026-03-06: sold 1,663 at $431.94 Form 4 ↗
2026-03-06Shannon Kelley, General Counsel$158,162
360 shno plan date144 ↗
Form 4, 2026-03-06: sold 360 at $431.94 Form 4 ↗
2026-03-06Carole Huntsman, Chief Commercial Officer$184,083
419 shno plan date144 ↗
Form 4, 2026-03-06: sold 419 at $431.94 Form 4 ↗
2026-03-06Rebecca Taub, Director$215,716
491 shplan 2025-09-10144 ↗
Form 4, 2026-03-06: sold 491 at $431.94 Form 4 ↗
2026-03-02Mardi Dier, EVP and CFO$511,056
1,183 shplan 2025-09-02144 ↗
Form 4, 2026-03-02: sold 1,183 at $427.21 Form 4 ↗
2026-01-26CAROLE A HUNTSMAN, Chief Commercial Officer$273,857
570 shplan 2024-11-05144 ↗
Form 4, 2026-01-26: sold 910 at $493.78 Form 4 ↗
2026-01-26Carole Huntsman, Chief Commercial Officer$163,353
340 shno plan dateno Form 4 on file144 ↗
2026-01-26William Sibold, President and CEO$757,670
1,577 shno plan date144 ↗
Form 4, 2026-01-26: sold 1,577 at $492.42 Form 4 ↗
2026-01-26Rebecca Taub, Director$310,851
647 shplan 2025-09-10144 ↗
Form 4, 2026-01-26: sold 647 at $492.42 Form 4 ↗
2026-01-20SHANNON KELLEY, General Counsel$215,221
429 shplan 2024-11-07144 ↗
Form 4, 2026-01-20: sold 692 at $497.36 Form 4 ↗
2026-01-20Shannon Kelley, General Counsel$131,942
263 shno plan dateno Form 4 on file144 ↗
2026-01-20Rebecca Taub, Director$1,122,760
2,238 shplan 2025-09-10144 ↗
Form 4, 2026-01-20: sold 2,238 at $490.77 Form 4 ↗
2026-01-09REBECCA A TAUB, Director$10.4M
18,650 shplan 2025-09-10144 ↗
Form 4, 2026-01-13: sold 18,410 at $522.40 Form 4 ↗
2025-12-10PAUL FRIEDMAN, Director$27.5M
49,600 shplan 2025-09-10144 ↗
Form 4, 2025-12-12: sold 24,800 at $552.18 Form 4 ↗
2025-12-10REBECCA A TAUB, Director$10.3M
18,650 shplan 2025-09-10144 ↗
Form 4, 2025-12-12: sold 18,650 at $552.15 Form 4 ↗
2025-12-04William John Sibold, President and CEO$1,391,736
2,400 shno plan date144 ↗
Form 4, 2025-12-04: sold 2,400 at $575.34 Form 4 ↗
2025-12-02MARDI C DIER, EVP and CFO$2,418,045
4,173 shplan 2025-09-02144 ↗
Form 4, 2025-12-03: sold 4,173 at $578.34 Form 4 ↗
2025-11-21Carole Huntsman, Chief Commercial Officer$1,061,471
1,958 shplan 2024-11-05144 ↗
Form 4, 2025-11-21: sold 1,958 at $553.11 Form 4 ↗
2025-11-13RICHARD S LEVY, Director$4,495,990
8,500 shplan 2025-08-14144 ↗
Form 4, 2025-11-14: sold 8,500 at $520.96 Form 4 ↗
2025-11-05KENNETH M BATE, Director$8,027,354
16,575 shno plan date144 ↗
Form 4, 2025-11-07: sold 16,575 at $484.31 Form 4 ↗